Literature DB >> 23196324

Rheumatic manifestations of cocaine use.

Jonathan Graf1.   

Abstract

PURPOSE OF REVIEW: Cocaine use is associated with several rheumatic syndromes. This review summarizes these clinical manifestations and highlights recent developments linked to levamisole-adulterated cocaine. RECENT
FINDINGS: Cocaine use has been linked to several distinctive syndromes that can be difficult to distinguish from idiopathic rheumatic diseases. These disorders can range in severity from purely cosmetic damage to organ and/or life-threatening disease that includes sinonasal destruction and vasculitis. Many of these illnesses are associated with antineutrophil cytoplasmic antibodies (cytoplasmic, perinuclear and atypical perinuclear patterns). With the recent introduction of levamisole as a cocaine adulterant, a newly reported syndrome has emerged that is associated with neutropenia, retiform purpura with cutaneous necrosis and autoantibodies consisting of high-titre perinuclear antineutrophil cytoplasmic antibodies (p-ANCAs) with specificities for 'atypical' antigens.
SUMMARY: Cocaine use is associated with clinical syndromes that closely mimic other primary rheumatic diseases. Given the high prevalence of cocaine use and its adulteration with levamisole, clinicians should be familiar with these rheumatic manifestations in order to avoid misdiagnosis and unnecessary treatment with potentially toxic therapies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23196324     DOI: 10.1097/BOR.0b013e32835b4449

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  14 in total

Review 1.  Cocaine-Levamisole-Induced Vasculitis/Vasculopathy Syndrome.

Authors:  Javier Marquez; Lina Aguirre; Carolina Muñoz; Andres Echeverri; Mauricio Restrepo; Luis F Pinto
Journal:  Curr Rheumatol Rep       Date:  2017-06       Impact factor: 4.592

2.  Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity.

Authors:  Christian Lood; Grant C Hughes
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

3.  A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.

Authors:  Carmelo Carmona-Rivera; Monica M Purmalek; Erica Moore; Meryl Waldman; Peter J Walter; H Martin Garraffo; Karran A Phillips; Kenzie L Preston; Jonathan Graf; Mariana J Kaplan; Peter C Grayson
Journal:  JCI Insight       Date:  2017-02-09

Review 4.  Key advances in the clinical approach to ANCA-associated vasculitis.

Authors:  Cees G M Kallenberg
Journal:  Nat Rev Rheumatol       Date:  2014-07-01       Impact factor: 20.543

5.  Activated STING in a vascular and pulmonary syndrome.

Authors:  Y Liu; A A Jesus; B Marrero; Z Deng; M Boehm; A S Paller; D Yang; S E Ramsey; G A Montealegre Sanchez; K Tenbrock; H Wittkowski; O Y Jones; H S Kuehn; C-C R Lee; M A DiMattia; E W Cowen; B Gonzalez; I Palmer; J J DiGiovanna; A Biancotto; H Kim; W L Tsai; A M Trier; Y Huang; D L Stone; S Hill; H J Kim; C St Hilaire; S Gurprasad; N Plass; D Chapelle; I Horkayne-Szakaly; D Foell; A Barysenka; F Candotti; S M Holland; J D Hughes; H Mehmet; A C Issekutz; M Raffeld; J McElwee; J R Fontana; C P Minniti; S Moir; D L Kastner; M Gadina; A C Steven; P T Wingfield; S R Brooks; S D Rosenzweig; T A Fleisher; R Goldbach-Mansky
Journal:  N Engl J Med       Date:  2014-07-16       Impact factor: 91.245

Review 6.  [Cocaine-induced vasculitis and mimics of vasculitis].

Authors:  Nikolas Ruffer; Martin Krusche; Konstanze Holl-Ulrich; Ina Kötter; Fabian Lötscher
Journal:  Z Rheumatol       Date:  2022-05-25       Impact factor: 1.372

7.  Recurrent episodes of hemorrhagic alveolitis in relapsing catastrophic antiphospholipid syndrome: the same side of the dark moon.

Authors:  Filippo Pieralli; Maddalena Grazzini; Vieri Vannucchi; Antonio Mancini; Daniele Cammelli; Carlo Nozzoli
Journal:  Clin Rheumatol       Date:  2013-12-21       Impact factor: 2.980

Review 8.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

Review 9.  Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

Review 10.  Pathologic manifestations of levamisole-adulterated cocaine exposure.

Authors:  Amber L Nolan; Kuang-Yu Jen
Journal:  Diagn Pathol       Date:  2015-05-06       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.